Stability Clinical Trials in Paris
6 recruitingParis, France
Showing 1–6 of 6 trials
Recruiting
Phase 1
AMG 436 as Monotherapy and Combination Therapy in Participants With MSI-H/dMMR Solid Tumors
Metastatic or Locally Advanced Solid Tumors With Microsatellite Instability-high (MSI-H) or Mismatched Repair Deficiency (dMMR)
Amgen464 enrolled21 locationsNCT07403721
Recruiting
Phase 1Phase 2
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
MelanomaSolid TumorLymphoma+2 more
Merck Sharp & Dohme LLC370 enrolled16 locationsNCT02332668
Recruiting
Prospective National Cohort Evaluating Predictive Biomarkers of Resistance to Immunotherapy in Patients With MSI/dMMR Metastatic Colorectal Cancer (CORESIM)
Colorectal Cancer MetastaticMicrosatellite Instability-High Colorectal Cancer
Federation Francophone de Cancerologie Digestive600 enrolled20 locationsNCT06353854
Recruiting
Phase 3
Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO
Triple-Negative Breast CancerCervical CancerUrothelial Carcinoma+12 more
UNICANCER646 enrolled40 locationsNCT05078047
Recruiting
Thoracic Fluid Content During Stabilization and Therapeutic De-escalation in Septic Shock
SepsisSeptic ShockFluid Overload+1 more
University Hospital, Brest50 enrolled2 locationsNCT06572995
Recruiting
Not Applicable
Evaluation of the Physiological Stability Variability and Robustness of NIS4
Evaluate the Physiological Stability of NIS4 Biomarker Between the Fed and Fasting State in Patients With the Target Condition (NAFLD)
CerbaXpert50 enrolled1 locationNCT06159257